Submit Release

EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

World Media Directory · RSS · Email Newsletters

There were 1,265 press releases posted in the last 24 hours and 429,771 in the last 365 days.

b3c newswire Press Releases

1,798 Press Releases

Published on December 7, 2017 - 08:12 GMT

Agendia and UZ Leuven Partner to Co-Validate MammaPrint® BluePrint® Breast Cancer Risk of Recurrence and Molecular Subtyping Kit ...

Irvine, CA, USA, Amsterdam, Netherlands and Leuven, Belgium, December 07, 2017 / B3C newswire / -- Agendia, a world leader in personalized medicine and molecular cancer diagnostics, and University Hospitals Leuven (UZ Leuven) in Belgium have partnered to …

Distribution channels: Technology
Published on December 6, 2017 - 14:31 GMT

Vetter Receives Corporate Health Award’s Recognition of Excellence

Provider of prefilled drug-delivery systems recognized for its occupational health management Award highlights company’s commitment to occupational health management Achievement acknowledges targeted investments in creating and expanding a sustainable …

Distribution channels: Technology
Published on December 5, 2017 - 08:22 GMT

Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint® BluePrint® Breast Cancer Kit Co-Validation ...

Institut Curie is one of an increasing number of major European cancer centers to become a co-validation partner for the new NGS-based MammaPrint BluePrint Kit Irvine, CA, USA, Amsterdam, the Netherlands, and Paris, France, December 05, 2017 / B3C newswire …

Distribution channels: Technology
Published on December 1, 2017 - 08:10 GMT

Polyganics Awarded €1.2 Million to Complete Clinical Development of Dura Sealant Patch

First-in-human clinical studies of the device expected to begin in early 2018 Groningen, The Netherlands, December 01, 2017 / B3C newswire / -- Polyganics, a privately held medical technology company that develops, manufactures and commercializes …

Distribution channels: Technology
Published on November 30, 2017 - 14:17 GMT

New Data at the San Antonio Breast Cancer Symposium Demonstrate the Value of MammaPrint® and BluePrint® Across Breast Cancer ...

Irvine, CA, USA and Amsterdam, the Netherlands, November 30, 2017 / B3C newswire / -- Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces the presentation of extensive new data at the upcoming 2017 San Antonio …

Distribution channels: Technology
Published on November 30, 2017 - 13:05 GMT

Selvita Promotes Edyta Jaworska to the Management Board to Strengthen Development in Integrated Drug Discovery Services

Krakow, Poland, November 30, 2017 / B3C newswire / -- The Supervisory Board of Selvita S.A. (WSE:SLV) has appointed Mrs. Edyta Jaworska to the position of a Management Board Member, responsible for the development of its integrated drug discovery services. …

Distribution channels: Technology
Published on November 30, 2017 - 08:04 GMT

Orchard Therapeutics Announces Expansion of Technical Operations in California

London, UK, November 30, 2017 / B3C newswire / -- Orchard Therapeutics (“Orchard”), a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the opening of …

Distribution channels: Technology
Published on November 29, 2017 - 13:16 GMT

Second Sartorius Research Xchange Forum Focuses On Regenerative Medicine and Cell Therapy

Event for experts from academia and industry on March 20 and 21, 2018 Lectures by academia and industry experts Guest lecture to be held by Nobel Prize laureate Dr. Stefan W. Hell Presentation of “The Sartorius & Science Prize for Regenerative Medicine …

Distribution channels: Technology
Published on November 28, 2017 - 14:23 GMT

Agendia’s MammaPrint® Breast Cancer Risk-of-Recurrence Test Obtains Favorable Final Payment Determination from CMS for New, Unique ...

CMS established the 2018 payment rate for MammaPrint’s new CPT code 81521 thus securing continued access to MammaPrint for Medicare/Medicaid beneficiaries The new determination and increased allowance follows an impressive Q3 which saw MammaPrint’s U.S. …

Distribution channels: Technology
Published on November 28, 2017 - 10:11 GMT

NBE-Therapeutics Appoints Dr. Nicole Onetto to Its Board of Directors

Basel, Switzerland, November 28, 2017 / B3C newswire / -- Today NBE Therapeutics AG, a biopharmaceutical company developing next-generation antibody drug conjugates (ADCs) carrying highly potent, immune-stimulatory anthracycline toxins, announces the …

Distribution channels: Technology
Published on November 28, 2017 - 10:11 GMT

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

Prague, Czech Republic, November 28, 2017 / B3C newswire / -- SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient to a Phase II study testing DCVAC/OvCa in combination with standard of care …

Distribution channels: Technology
Published on November 28, 2017 - 08:23 GMT

Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials

Maastricht, The Netherlands, November 28, 2017 / B3C newswire / -- Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, today …

Distribution channels: Technology
Published on November 27, 2017 - 08:23 GMT

Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B

London & Manchester, UK, November 27, 2017 / B3C newswire / -- Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, …

Distribution channels: Technology
Published on November 21, 2017 - 12:20 GMT

Lead Pharma Achieves Third Milestone in Sanofi Collaboration for Development of Autoimmune Diseases Treatments

Progress in collaboration triggers undisclosed third milestone payment Nijmegen, The Netherlands, November 21, 2017 / B3C newswire / -- Lead Pharma, a pharmaceutical company developing innovative medicines for the treatment of immunological and oncological …

Distribution channels: Technology
Published on November 20, 2017 - 14:29 GMT

AJCC Confirms MammaPrint's Clinical Utility for Treatment Decisions and Staging in Recent 8th Edition Breast Chapter Update

Update clarifies that the patient and clinician may choose any genomic profile or multigene panel based on available clinical evidence at the time of treatment In line with recent publications from NEJM and ASCO, the AJCC now recognizes MammaPrint with …

Distribution channels: Technology
Published on November 20, 2017 - 09:07 GMT

leon-nanodrugs Congratulates its Partner MJR Pharmjet on Receiving Prestigious CPhI Award 2017 for Highly Innovative MicroJet ...

Munich, Germany, November 20, 2017 / B3C newswire / -- The CPhI Pharma Awards are among the most prestigious recognitions within the pharmaceutical industry. MJR PharmJet, partner of leon-nanodrugs GmbH in drug development received one of this year’s …

Distribution channels: Technology
Published on November 17, 2017 - 15:02 GMT

Successful First-in-Human Testing of Implandata’s Next Generation EYEMATE™ Micro-Sensor for Improved Monitoring of Glaucoma ...

Hannover, Germany, November 17, 2017 / B3C newswire / --Implandata Ophthalmic Products GmbH (Implandata) is a privately held, ISO 13485 certified medical device company founded in 2010 in Hannover/Germany. Implandata’s EYEMATE™ system for continuous …

Distribution channels: Technology
Published on November 9, 2017 - 15:23 GMT

Vetter Expands its Footprint in Asia Pacific Region

Company establishes its presence in South Korea Additional footprint in Asia Pacific region New office underlines company’s commitment to its customers in South Korea Songdo, South Korea and Ravensburg, Germany, November 09, 2017 / B3C newswire / -- …

Distribution channels: Technology
Published on November 9, 2017 - 13:29 GMT

RedHill Biopharma Announces Last Patient Enrolled in the Phase III Study with RHB-104 for Crohn's Disease

Top-line results are expected to be announced in mid-2018 The Phase III study evaluating RHB-104 for Crohn’s disease (MAP US study) is a randomized, double-blind, placebo-controlled study that is evaluating the safety and efficacy of RHB-104 in 331 …

Distribution channels: Technology
Published on November 9, 2017 - 09:27 GMT

apceth Biopharma Appoints a New Supervisory Board

Munich, Germany, November 09, 2017 / B3C newswire / -- apceth Biopharma GmbH, a leading company developing the next generation of cell-based therapies, announced today the appointment of a new Supervisory Board. The Supervisory Board will be responsible …

Distribution channels: Technology

Previous 20 21 22 23 24 25 26 27 28 29 30 Next